Epilepsia y antiepilépticos de primera y segunda generación. Aspectos básicos útiles en la práctica clínica
暂无分享,去创建一个
[1] P. Kellaway,et al. Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures , 1981, Epilepsia.
[2] H. Merritt,et al. SODIUM DIPHENYL HYDANTOINATE IN THE TREATMENT OF CONVULSIVE DISORDERS , 1938 .
[3] nominatif de l’habitat,et al. Definitions , 1964, Innovation Dynamics and Policy in the Energy Sector.
[4] B. Söderpalm. Anticonvulsants: aspects of their mechanisms of action , 2002, European journal of pain.
[5] M. Morrell. Differential diagnosis of seizures. , 1993, Neurologic clinics.
[6] S. Blom. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). , 1962, Lancet.
[7] G. Mathern,et al. Epilepsia , 1991, NEURO FUNDAMENTAL.
[8] Helen Clough,et al. Carbamazepine versus Valproate Monotherapy for Epilepsy: A Meta‐analysis , 2002, Epilepsia.
[9] P. V. Van Ness,et al. Evolving treatment strategies for epilepsy. , 2002, JAMA.
[10] S. Wiebe,et al. Cost‐Effectiveness of Epilepsy Therapy: How Should Treatment Effects Be Measured? , 2002, Epilepsia.
[11] Rüdiger Köhling,et al. GABA Becomes Exciting , 2002, Science.
[12] W. Catterall,et al. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. , 1985, Molecular pharmacology.